BRPI0818338A2 - Composto de pirimidil indolina - Google Patents

Composto de pirimidil indolina

Info

Publication number
BRPI0818338A2
BRPI0818338A2 BRPI0818338A BRPI0818338A2 BR PI0818338 A2 BRPI0818338 A2 BR PI0818338A2 BR PI0818338 A BRPI0818338 A BR PI0818338A BR PI0818338 A2 BRPI0818338 A2 BR PI0818338A2
Authority
BR
Brazil
Prior art keywords
pyrimidil
indoline
compound
pyrimidil compound
indoline pyrimidil
Prior art date
Application number
Other languages
English (en)
Inventor
Toshio Kaneko
Takeshi Shida
Koji Matsumoto
Kazumasa Aoki
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of BRPI0818338A2 publication Critical patent/BRPI0818338A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0818338 2007-10-16 2008-10-15 Composto de pirimidil indolina BRPI0818338A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007268937 2007-10-16
PCT/JP2008/068607 WO2009051119A1 (ja) 2007-10-16 2008-10-15 ピリミジルインドリン化合物

Publications (1)

Publication Number Publication Date
BRPI0818338A2 true BRPI0818338A2 (pt) 2015-04-22

Family

ID=40567381

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818338 BRPI0818338A2 (pt) 2007-10-16 2008-10-15 Composto de pirimidil indolina

Country Status (16)

Country Link
US (1) US8232287B2 (pt)
EP (1) EP2210886B1 (pt)
JP (1) JP5317354B2 (pt)
KR (1) KR101536021B1 (pt)
CN (1) CN101896481B (pt)
AU (1) AU2008312948C1 (pt)
BR (1) BRPI0818338A2 (pt)
CA (1) CA2710182C (pt)
IL (1) IL205057A0 (pt)
MX (1) MX2010004232A (pt)
MY (1) MY151295A (pt)
NZ (1) NZ585284A (pt)
RU (1) RU2464269C2 (pt)
TW (1) TWI421074B (pt)
WO (1) WO2009051119A1 (pt)
ZA (1) ZA201002552B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2399914A4 (en) * 2009-02-18 2012-08-29 Takeda Pharmaceutical FUSED HETEROCYCLIC CORE COMPOUND
CA2759843A1 (en) * 2009-05-08 2010-11-10 Pfizer Inc. Gpr 119 modulators
US20120052130A1 (en) * 2009-05-08 2012-03-01 Pfizer Inc. Gpr 119 modulators
NZ596445A (en) 2009-06-24 2013-04-26 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
TW201113269A (en) * 2009-06-24 2011-04-16 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
EP2462123B1 (en) * 2009-08-04 2013-10-02 Merck Sharp & Dohme Corp. 4,5,6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
EP2474540A4 (en) * 2009-08-31 2013-03-13 Nippon Chemiphar Co GPR119 AGONIST
JP2013511571A (ja) * 2009-11-23 2013-04-04 ファイザー・インク Ｇｐｒ１１９阻害剤としてのイミダゾ−ピラゾール
RU2012135525A (ru) 2010-01-20 2014-02-27 Санофи Производные алкилгетероциклических карбаматов, их получение и применение в терапии
FR2955580A1 (fr) * 2010-01-28 2011-07-29 Sanofi Aventis Derives de carbamate d'alkyl-heterocycles, leur preparation et leur application en therapeutique
TW201204733A (en) 2010-06-25 2012-02-01 Kowa Co Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
WO2012025811A1 (en) * 2010-08-23 2012-03-01 Lupin Limited Indolylpyrimidines as modulators of gpr119
DK2625177T3 (en) * 2010-10-08 2015-10-12 Cadila Healthcare Ltd New GPR 119 agonists
CA2818050A1 (en) 2010-11-26 2012-05-31 Lupin Limited Bicyclic gpr119 modulators
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP3009433B1 (en) 2012-01-18 2017-06-21 Daiichi Sankyo Company, Limited 2-phenyl-1,3-oxazole and 5-phenyl-1,2,4-oxadiazole derivatives for the treatment of diabetes
US20160060235A1 (en) * 2013-03-29 2016-03-03 National University Corporation Kumamoto University Therapeutic Agent for Type 2 Diabetes
US12577217B2 (en) * 2019-01-08 2026-03-17 Kyorin Pharmaceutical Co., Ltd. 15-PGDH inhibitor
JP7532385B2 (ja) 2019-01-31 2024-08-13 杏林製薬株式会社 １５－ｐｇｄｈ阻害薬

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
IL149103A0 (en) 1999-11-30 2002-11-10 Pfizer Prod Inc 2,4-diaminopyrimidine compounds useful as immunosuppressants
US7101869B2 (en) 1999-11-30 2006-09-05 Pfizer Inc. 2,4-diaminopyrimidine compounds useful as immunosuppressants
SI1645558T1 (sl) 2002-06-19 2008-10-31 Biovitrum Ab Publ Piperazinilpirazini kot modulatorji serotonin 5-HT2C receptorja
US7078419B2 (en) * 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
CN100509798C (zh) * 2003-07-11 2009-07-08 艾尼纳制药公司 作为新陈代谢调节剂的三取代芳基和杂芳基衍生物以及预防和治疗与其相关之病症
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
FR2866884B1 (fr) 2004-02-26 2007-08-31 Sanofi Synthelabo Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
HRP20090093T3 (en) * 2004-06-04 2009-03-31 Arena Pharmaceuticals Inc. Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP2308840A1 (en) 2005-06-30 2011-04-13 Prosidion Limited GPCR agonists
CN101511429A (zh) * 2006-07-13 2009-08-19 史密丝克莱恩比彻姆公司 二氢吲哚衍生物和gpr119激动剂

Also Published As

Publication number Publication date
CN101896481B (zh) 2014-04-30
ZA201002552B (en) 2011-10-26
EP2210886A1 (en) 2010-07-28
US20100292259A1 (en) 2010-11-18
AU2008312948C1 (en) 2012-08-09
AU2008312948A1 (en) 2009-04-23
MX2010004232A (es) 2010-09-30
RU2010119487A (ru) 2011-11-27
WO2009051119A1 (ja) 2009-04-23
CN101896481A (zh) 2010-11-24
EP2210886A4 (en) 2011-08-17
NZ585284A (en) 2011-03-31
CA2710182C (en) 2012-08-14
TW200922588A (en) 2009-06-01
KR101536021B1 (ko) 2015-07-10
EP2210886B1 (en) 2015-09-23
RU2464269C2 (ru) 2012-10-20
TWI421074B (zh) 2014-01-01
IL205057A0 (en) 2010-11-30
JPWO2009051119A1 (ja) 2011-03-03
KR20100071068A (ko) 2010-06-28
CA2710182A1 (en) 2009-04-23
JP5317354B2 (ja) 2013-10-16
MY151295A (en) 2014-04-30
AU2008312948B2 (en) 2012-03-01
US8232287B2 (en) 2012-07-31

Similar Documents

Publication Publication Date Title
BRPI0818338A2 (pt) Composto de pirimidil indolina
BRPI0815042A2 (pt) Compostos de pirazol
ATE502948T1 (de) Substituierte bicyclolactamverbindungen
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
EP2226315A4 (en) 2-aminoquinazoline DERIVATIVE
EP2170350A4 (en) SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
EP2079466A4 (en) SUBSTITUTED INDOLE COMPOUNDS
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
BRPI0811264A2 (pt) Compostos
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0914942A2 (pt) Compostos de oxindol
BRPI0809996A2 (pt) Compostos
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0814718A2 (pt) Derivados de isoxazol-imidazol
BRPI0923592A2 (pt) composto
BRPI0815181A2 (pt) Compostos
BRPI0911393A2 (pt) composto de 5-hidroxipirimidina-4-carboxamida
BRPI0909209A2 (pt) Composto indolinona

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]